One conviction:
diagnose earlier, save lives.
Uterine cancer
has been left behind.
Breast cancer has the mammogram. Cervical cancer has the Pap smear. Decades of awareness, research, and clinical advancement have transformed how we catch both — earlier, more reliably, more routinely.
Endometrial cancer hasn’t followed that story. It has long been perceived as lower risk — but mortality is rising. It’s increasingly affecting younger women, with rising rates of more aggressive subtypes and evolving risk factors.123 We built a sampler that collects three ways: by suction, brushing and absorption, in a single device.
We envision a world where endometrial cancer
is caught before symptoms appear
We’re championing a new standard of care where every woman knows her risk and has access to early diagnosis. That is our mission as a company. Our goals:
Work toward a timely diagnosis for every woman with symptoms
Expand access to early detection for high-risk women, before symptoms appear
Support the research needed before routine endometrial screening can become standard practice
Utepreva for your practice
See how it works. Request a demonstration for your practice.
Suction, brushing and absorption, in one endometrial sampler.
